Quipt Home Medical Corp. (QIPT)

4,0300 0,0000 (0,00%) Alla chiusura: 04:00PM EDT

Quipt Home Medical Corp.

1019 Town Drive
Wilder, KY 41076
United States
859 878 2220
https://quipthomemedical.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Gregory J. Crawford	Chairman, President & CEO	901,35k	N/D	N/D
Mr. Hardik Mehta	Chief Financial Officer	761,49k	N/D	N/D
Mr. David Bachelder	Executive Vice President of Operations	N/D	N/D	N/D
Mr. William Todd Zehnder	Chief Strategy Officer & Investor Relations	308,24k	N/D	1975
Cole Stevens	VP of Corporate Development & VP of Investor Relations	N/D	N/D	N/D
Mr. Mark Miles	Vice President of Information Technology	N/D	N/D	N/D
Mr. Thomas W. Roehrig	Executive Vice President of Finance	N/D	N/D	1966
Mr. Robert Grossman LLB	Corporate Secretary	N/D	N/D	1974

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Governance aziendale

L'ISS Governance QualityScore di Quipt Home Medical Corp. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.